Summit Therapeutics Share Discussion Threads

[hugus maximus] 25/7/2017 18:22

Apologies Waterloo ... of course ... you meant a 52 week high ... I was assuming you meant the year "2017". Last autumn Sarepeta's licensing deal prompted a huge share price spike.

Hoping eager anticipation is met with something concrete re: RDZ deal, the NASDAQ may indeed have no idea of Summit's C Diff drug.

[waterloo01] 25/7/2017 17:47

52 week high was $19.75 according to Nasdaq. Just about to hit $13.00

[solomon] 25/7/2017 17:20

SMMT is one of Zacks' big tips (again). I guess we are all too long in the market (and tooth) to be entertained by such an upstart.

[hugus maximus] 25/7/2017 16:27

Many interesting thoughts there Waterloo and sparky Luminoso.
Edit ... did you mean "year high - $13"?

[waterloo01] 25/7/2017 15:33

Hugus, I don't expect it to drop back but if anything move closer to the year high ($19.00 or there about). Broker consensus is around $24/$28 and certainly any RDZ positive news would see this drive higher (don't think that many in the US are even aware of RDZ).

Otherwise, as I posted a last week, if the current trial is unequivocal, then can't see SRPT paying 45% of ongoing trial costs without US rights, however our major holders will want a major return, so who knows at what price?

However, they have the money now, so wouldn't be that surprised to see some deal constructed where they secure all rights in return for cash/serious milestones on this phase results and on approvals or even a merger of some sort. All IMO

[luminoso] 25/7/2017 15:17

Only in my dreams, Hugus !
Nasdaq started sparky.

[hugus maximus] 25/7/2017 15:00

Luminoso ... so talk of £20 parties no longer anticipated?

[hugus maximus] 25/7/2017 14:53

Waterloo - the NASDAQ seems to be holding above $12.50 as requested!

[luminoso] 25/7/2017 14:47

Another scenario that I have never considered before is SRPT taking all of the DMD programme off us and leaving us with C.Diff and a shed load of cash. Well, a few sheds......

[luminoso] 25/7/2017 14:45

I'll take it !

[solomon] 25/7/2017 12:54

Yep, they could offer just over £9 per share with their available funds.

[chrisatrdg] 25/7/2017 12:09

Buy Summit?

[waterloo01] 25/7/2017 12:08

$300M in cash, $100M line of credit, $325M raise . . . What's Sarepta going to do with all that $$?

[waterloo01] 24/7/2017 14:43

As I said a few days ago, need $12.50 to hold (right at that now). Think it will once the SRPT news sinks in. Part of their raising is either to 'acquire' or to fund trials (ie their own and ours) IMO

[waterloo01] 24/7/2017 13:00

They already have around $300m in cash so looks like they are building a war chest!

[football] 24/7/2017 12:03

That's a relief with the share price falling this morning I was expecting bad news at noon

[hugus maximus] 24/7/2017 11:43

The phrase "lack of transparency" comes to mind when watching the share price change in response to what is supposedly reported "trades" ... talk about blindman's buff!

[football] 21/7/2017 16:06

What is it with this share as any movement upwards in the USA it takes ages to catch up and follow the trend but the slightest fall and we immediately follow it over here

[tightfist] 21/7/2017 11:29

Cup and Handle formation close to completing on NASDAQ/SMMT, spread closed-up on AIM although at minimal volume.....

[luminoso] 21/7/2017 09:30

As Hugus said, the current appetite for Biotechs is not what it was a couple of years ago. Sentiment is everything.
However, those heady days could return but I am not counting on it.

[bewise2] 20/7/2017 23:43

My speculative thinking is based on the previous price of Sarepta which had climbed to over $60 at one point,why could this not happen to Summ if our treatment is proven to sucessfully treat all boys!

[hugus maximus] 20/7/2017 23:04

Bewise2 ... I do not have the general market experience of many folk here, but given the recent share price levels, I suspect many might be pleased with £5 if there is some significant show of promise in the 24 week study? (and C Diff P3 is funded without dilution) Sadly the market doesn't seem to wade in like it used to do since I started here just 5 years ago. I do remember £4 being achieved 4 years ago with nothing but promise of the DMD P1 trials. However I have lowered my expectations ... though will of course be thrilled to see things move above.

This sort of speculation is probably very difficult ... and indeed as a result perhaps the company might be taken out far too cheaply? I hope not as I think they are a great outfit.

[bewise2] 20/7/2017 22:12

I have been a Summ holder for quite a lot of years, how far could this share price go on successful transforming results Q1 2018 not to mention CDiff...are we talking £15-£20+a share or am i being to optimistic!

[chrisatrdg] 20/7/2017 21:39

I agree with waterloo01 there may be an offer next year especially if there is not a significant increase in share price following positive results as this would expose Summit to a takeover which might benefit us all.

I would end by saying that the NASDQ close which at current exchange rates is £2.03 might again be reflected in the AIM share price Friday.We have seen on a number of occasions a push in share price based on speculation that something good is around the corner & this may be repeated.Hold onto your seats.

[football] 20/7/2017 21:27

$13.42USD up 0.63 (4.93%)

so a red day tomorrow then